<DOC>
	<DOCNO>NCT02391883</DOCNO>
	<brief_summary>Patients Clopidogrel therapy alone combination acetylsalicylic acid ( Dual Antiplatelet Therapy ( DAPT ) present hip-fracture represent surgeon dilemma put patient risk major blood loss surgery , put patient risk thromboembolic event surgery . The investigator hypothesize risk major blood loss patient still effect Clopidogrel DAPT hip-fracture surgery relatively low . The investigator conduct retrospective observational study hip-fracture patient test hypothesis .</brief_summary>
	<brief_title>Hip-Fracture Surgery Patients Clopidogrel Therapy</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>All patient operate short intramedullary nail hipfractures , study period . ( 1st Jan. 201131st Dec. 2013 ) patient operate &gt; 24 hour admission , patient form anticoagulation medication except acetylsalicylic acid ( include vitamin K antagonist , dipyridamole , dabigatran , apixaban rivaroxaban ) , miss data blood loss patient chart , miss blood sample first 4 day extranational patient ( follow possible ) . Patients operate side inclusion period include data late operation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>clopidogrel therapy</keyword>
	<keyword>platelet aggregation inhibitor</keyword>
	<keyword>adverse event</keyword>
</DOC>